EDGAR Filing Documents for 0001193125-13-057515

Form 8-K - Current report:

SEC Accession No. 0001193125-13-057515

Filing Date

2013-02-14

Accepted

2013-02-14 07:46:35

Documents

Period of Report

2013-02-14

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d485981d8k.htm	8-K	15378
2	SAGENT PHARMACEUTICALS, INC. PRESS RELEASE, DATED FEBRUARY 14, 2013.	d485981dex991.htm	EX-99.1	203330
3	GRAPHIC	g485981ex99_1pg04f.jpg	GRAPHIC	8026
	Complete submission text file	0001193125-13-057515.txt		231219

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 13606264
SIC: 2834 Pharmaceutical Preparations